Phase 1 Trial Evaluating Cisplatin, Gemcitabine, and Veliparib in 2 Patient Cohorts: Germline BRCA Mutation Carriers and Wild-Type BRCA Pancreatic Ductal Adenocarcinoma

O'Reilly, EM; Lee, JW; Lowery, MA; Capanu, M; Stadler, ZK; Moore, MJ; Dhani, N; Kindler, HL; Estrella, H; Maynard, H; Golan, T; Segal, A; Salo-Mullen, EE; Yu, KH; Epstein, AS; Segal, M; Brenner, R; Do, RK; Chen, AP; Tang, LH; Kelsen, DP

O'Reilly, EM (reprint author), Mem Sloan Kettering Canc Ctr, Dept Med, 300 East 66th St, New York, NY 10065 USA.

CANCER, 2018; 124 (7): 1374

Abstract

BACKGROUND: A phase 1 trial was used to evaluate a combination of cisplatin, gemcitabine, and escalating doses of veliparib in patients with untreated......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索